American Heart Association argues that South Carolina bill H.4303 would benefit the tobacco industry at the expense of public ...

In veterans with type 2 diabetes, treatment with GLP-1 receptor agonists was associated with a reduced risk for various substance use disorders compared with sodium-glucose cotransporter-2, or SGLT-2, ...

Letters to the Editor this week include Trump's shifting reason for Iran attack, Ohio legislature overreach on Rank Choice, and halting youth vaping.

A growing body of research has looked at GLP-1 drugs for alcohol use disorder. A new study shows the medications could have a ...

Katy Perry shared with her fans that she hasn’t used nicotine in a few months. The "Teenage Dream" singer had previously ...

GLP-1 medications may also fight addiction, says Dr. Ziyad Al-Aly whose team researched trends from GLP-1 use in 600,000 ...

Founded by serial entrepreneur and CPG veteran Brad Pyatt, IQ Pouch introduces a nicotine-free performance pouch built for athletes, entrepreneurs, and modern high performers. DENVER, March 6, 2026 ...

A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders. An analysis of electronic health records of ...

My team and I set out to test whether GLP-1 drugs — medications like semaglutide (Ozempic and Wegovy) and tirzepatide ...

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.

A large new study suggests they may drastically reduce the risk substance use disorders and drug-related deaths.